eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
2/2017
vol. 68
 
Share:
Send email
Share:

Quiz. What is your diagnosis?

Anna Szumera-Ciećkiewicz
,
Barbara Bikowska-Opalach
,
Monika Prochorec-Sobieszek

Pol J Pathol 2017; 68 (2): 185
DOI: https://doi.org/10.5114/pjp.2017.69696
Online publish date: 2017/09/01
Article file
- Quiz what is your diagnosis.pdf  [0.33 MB]
Get citation
 
PlumX metrics:
 
An 85-year-old male with right inguinal lymphadenopathy and suspicion of prostate cancer was admitted to the Institute of Haematology and Transfusion Medicine. Microscopic examination of lymph nodes revealed abundant fields of cohesive CKAE1/AE3-positive cells and small to medium-sized lymphocytic infiltrate expressing CD20 and cyclin D1. Haematoxylin and eosin staining is presented in Figs. 1-3; additional immunohistochemical reactions: CKAE1/AE3, CD20, and cyclin D1 are depicted in Figs. 4-6, respectively.
Copyright: © 2017 Polish Association of Pathologists and the Polish Branch of the International Academy of Pathology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.